|
Market Closed -
Euronext Paris
18:55:00 31/08/2026 +03
|
Pre-market 09:16:31 | |||
| 163.10 EUR | -.--% |
|
163.20 | +0.06% |
| 08-21 | Ipsen S.A. completed the acquisition of Kartos Therapeutics, Inc. | CI |
| 08-21 | Ipsen Wraps Up Purchase of US-based Kartos Therapeutics | MT |
MarketScreener Strategies
Search
 | Ipsen: Another quarterly beat; 2026 guidance upgraded | July 30, 2026 at 04:49 pm |
 | Ipsen: Reassessing mid-term risks | July 06, 2026 at 03:00 pm |
| Ipsen: Beneficiary of favourable product mix and imminent readouts | May 27, 2026 at 10:30 am |
| Ipsen: Opened the year with encouraging traction | April 24, 2026 at 12:04 am |
| Ipsen: Markets applaud strong finish to 2025 and better-than-expected 2026 outlook | February 12, 2026 at 05:32 pm |
| Ipsen raises 2025 outlook after stronger Somatuline | November 17, 2025 at 04:10 pm |
No results match your criteria
- Stock Market
- Stocks
- IPN Stock
- News Ipsen
- MarketScreener Strategies
Select your edition
All financial news and data tailored to specific country editions
